Ahmed Velić

Dr. Ahmed Velić

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2023 in Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
BHBerina Hasanefendić
Berina Hasanefendić
EŠEmir Šeherčehajić
Emir Šeherčehajić
ADArmina Dedić
Armina Dedić
STSuzana Tihić-Kapidžić
Suzana Tihić-Kapidžić
EBErmin Begović
Ermin Begović
MDMelina Drljo
Melina Drljo
Introduction: The coronavirus disease 2019 (COVID-19) pandemic has caused a worldwide emergency. The disease is characterized primarily by symptoms of the respiratory system, but also by systemic inflammation. Since the onset of the disease, there has been a need for biomarkers to predict the severity of the clinical picture and the outcome of the disease. The aim of this study is to evaluate systemic inflammatory markers for predicting severity of COVID-19. Methods: The study was conducted at the Sarajevo Canton Health Center on a total of 170 adults suffering from COVID-19. 70 subjects had mild clinical picture, while the control group consisted of 100 subjects with moderate clinical picture. The results of complete and differential blood counts, C-reactive protein (CRP), and systemic inflammatory indexes (SII) (neutrophil/lymphocyte ratio [NLR], derived NLR [dNLR], platelet/lymphocyte ratio [PLR], and SII) were used to compare the groups. IBM SPSS Ver. 23 was used for statistical analysis and data processing. Results: The proportion of male patients in the group with a milder clinical picture was higher than the proportion of male patients with a moderate clinical picture, p = 0.016. The values of leukocytes and neutrophils were higher in patients with a moderate clinical picture (p = 0.006 and p < 0.001, respectively). The values of all inflammatory indexes (NLR, dNLR, PLR and SII) were higher in patients with a moderate clinical picture of COVID-19 than in patients with a mild clinical picture (p < 0.001 for NLR, dNLR, and SII; p = 0.023 for PLR). In the research, patient age showed no correlation and CRP showed no correlation with SII. Conclusion: SII show higher values in patients with a moderate compared with a mild clinical picture of COVID-19. These parameters can be cost-effective and useful indicators in patient classification, diagnosis, and probably in monitoring patients with COVID-19.

30 April 2025 in Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
BHBerina Hasanefendić
Berina Hasanefendić
APAleksandra Pašić
Aleksandra Pašić
LHLajla Halilović
Lajla Halilović
AVAhmed Velić
Ahmed Velić
JTJasna Topalović-Ćetković
Jasna Topalović-Ćetković
AFAmir Fazlagić
Amir Fazlagić
In our letter, we presented the challenges within medical biochemistry in a tertiary hospital in a measles outbreak. The letter somewhat shows the current situation in the first part. In the remaining part, the challenges in the work of the medical biochemical laboratory are listed and the significance of the most common biochemical and hematological analyzes for these patients is explained. This letter is an important clinical-epidemiological overview of the current situation that arose as a result of the measles outbreak.

13 October 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
Botond LakatosBotond Lakatos
Botond Lakatos
EBEmily Burzynski
Emily Burzynski
JCJanah Bou Chahine
Janah Bou Chahine
LBLeyla Bennacer
Leyla Bennacer
TKTetiana Koval
Tetiana Koval
Justyna Dominika KowalskaJustyna Dominika Kowalska
Justyna Dominika Kowalska
Human herpesvirus 8 (HHV-8) is associated with Kaposi sarcoma (KS), multicentric Castleman disease (MCD), and primary effusion lymphoma (PEL), important causes of morbidity among people living with HIV. Data on these diseases remain limited from Central and Eastern Europe compared with Western Europe. We conducted a multicentre cross-sectional survey, using an online questionnaire distributed to HIV physicians within the Euroguidelines in Central and Eastern Europe Network Group, comprising epidemiology, diagnostic capacity, and management of HHV-8-related diseases. Twenty-six HIV treatment centres from 22 countries participated, providing care for 36,845 people living with HIV. A total of 55 cases of KS (1.49 per 1000 PLWH) were reported, of which 35 (63.6%) had visceral involvement. MCD and PEL were uncommon, with 7 and 4 cases, respectively. Diagnostic capacity varied between centres: computed tomography was available in 80.8%, bronchoscopy in 30.8%, and gastroscopy in 23.1%. Antiretroviral therapy alone was the most common first-line treatment for limited KS, while pegylated liposomal doxorubicin was accessible as first-line and/or second-line treatment in 46.2% of centres. HHV-8-related diseases remain uncommon but clinically relevant complications of HIV infection in Central and Eastern Europe. Regional variability in diagnostic resources and treatment availability highlights the need for strengthened referral pathways and guideline-adherent care.